The non-proteolytically active thrombin peptide TP508 stimulates angiogenic sprouting

Area of Science:

• Biochemistry
• Molecular Biology
• Vascular Biology

Background:

• Thrombin, a serine protease, is crucial for hemostasis and tissue repair.
• A derived peptide, TP508, promotes tissue repair and vascularity independently of thrombin's proteolytic activity.
• TP508 activates cells via a non-proteolytic, non-PAR pathway, suggesting a novel signaling mechanism.

Purpose of the Study:

• To investigate the angiogenic potential of TP508.
• To elucidate the role of non-proteolytic thrombin pathways in angiogenesis.
• To compare TP508's angiogenic effects with VEGF and proteolytically active thrombin agonists.

Main Methods:

• Utilized an in vitro model of angiogenic sprouting using cultured microvessel fragments.
• Quantified angiogenic sprouting stimulated by TP508, VEGF, and proteolytically active receptor agonists.
• Assessed the involvement of VEGF and VEGF mRNA expression in TP508-mediated angiogenesis.

Main Results:

• TP508 significantly stimulated angiogenic sprouting, comparable to or exceeding VEGF.
• TP508 accelerated sprouting rate but did not increase the number of sprouts per vessel.
• Proteolytically active thrombin agonists showed no effect or inhibited sprouting.
• TP508-induced sprouting was VEGF-dependent but did not alter VEGF mRNA levels.

Conclusions:

• TP508 acts as an angiogenic factor through a non-proteolytic pathway.
• TP508 accelerates microvascular cell sprouting early in angiogenesis.
• The mechanism of TP508 differs from intact thrombin, highlighting a distinct non-PAR signaling role.